Pituitary-ovary-spleen axis in ovulation

Trends in Endocrinology and Metabolism

Volumn 22, Issue 9, 2011, Pages 345-352

  Oakley, Oliver R ^a   Frazer, Michele L ^b   Ko, CheMyong ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Hagyards Equine Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GONADORELIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LUTEINIZING HORMONE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; VASCULOTROPIN;

CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CORPUS LUTEUM; EOSINOPHIL; EXTRACELLULAR MATRIX; FEMALE INFERTILITY; HUMAN; HYPOPHYSIS; IMMUNE RESPONSE; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; LYMPHOCYTE; MACROPHAGE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OVARY; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPLEEN; SPLENECTOMY;

FEMALE; HUMANS; LEUKOCYTES; OVARY; OVULATION; PITUITARY GLAND; SPLEEN;

EID: 80052370553     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.04.005     Document Type: Review

References (123)

1. Urman B., Yakin K. Ovulatory disorders and infertility. J. Reprod. Med. 2006, 51:267-282.
2. Gibson M. Reproductive health and polycystic ovary syndrome. Am. J. Med. 1995, 98:67S-75S.
3. Mitwally M.F., Casper R.F. Potential of aromatase inhibitors for ovulation and superovulation induction in infertile women. Drugs 2006, 66:2149-2160.
4. Cremer M., et al. Recent innovations in oral contraception. Semin. Reprod. Med. 2010, 28:140-146.
5. Oakley O.R., et al. Periovulatory leukocyte infiltration in the rat ovary. Endocrinology 2010, 151:4551-4559.
6. Hedin L. Invaders from the spleen: an unexpected origin of the leukocytes participating in ovulation. Endocrinology 2010, 151:4096-4099.
7. Swirski F.K., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
8. Kitaya K., Yamada H. Pathophysiological roles of chemokines in human reproduction: an overview. Am. J. Reprod. Immunol. 2010, 65:449-459.
9. Runesson E., et al. The human preovulatory follicle is a source of the chemotactic cytokine interleukin-8. Mol. Hum. Reprod. 1996, 2:245-250.
10. Arici A., et al. Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells. Endocrinology 1996, 137:3762-3769.
11. Bukulmez O., Arici A. Leukocytes in ovarian function. Hum. Reprod. Update 2000, 6:1-15.
12. Karaca T., et al. Distribution and heterogeneity of mast cells in female reproductive tract and ovary on different days of the oestrus cycle in Angora goats. Reprod. Domest. Anim. 2008, 43:451-456.
13. Smith M.P., et al. Leukocyte origin and profile in follicular aspirates at oocyte retrieval. Hum. Reprod. 2005, 20:3526-3531.
14. Bonello N., et al. Periovulatory expression of intercellular adhesion molecule-1 in the rat ovary. Biol. Reprod. 2004, 71:1384-1390.
15. Rohm F., et al. Correlation between expression of selectins and migration of eosinophils into the bovine ovary during the periovulatory period. Cell Tissue Res. 2002, 309:313-322.
16. Robker R.L., et al. The inflammatory response at ovulation is altered in ovaries of progesterone receptor null (PRKO) mice. In 43rd Annual Meeting of the Society for the Study of Reproduction 2010, abstract #95.
17. Simon C., et al. Interleukin-1 receptor antagonist suppresses human chorionic gonadotropin-induced ovulation in the rat. Biol. Reprod. 1994, 51:662-667.
18. Langer H.F., Chavakis T. Leukocyte-endothelial interactions in inflammation. J. Cell. Mol. Med. 2009, 13:1211-1220.
19. Murayama C., et al. Effect of VEGF (vascular endothelial growth factor) on expression of IL-8 (interleukin-8) IL-1beta and their receptors in bovine theca cells. Cell Biol. Int. 2010, 34:531-536.
20. Kawano Y., et al. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a). Am. J. Reprod. Immunol. 2007, 58:434-439.
21. Liptak A.R., et al. Cooperative expression of monocyte chemoattractant protein 1 within the bovine corpus luteum: evidence of immune cell-endothelial cell interactions in a coculture system. Biol. Reprod. 2005, 72:1169-1176.
22. Polec A., et al. Cellular interaction regulates interleukin-8 secretion by granulosa-lutein cells and monocytes/macrophages. Am. J. Reprod. Immunol. 2009, 61:85-94.
23. Dahm-Kahler P., et al. Monocyte chemotactic protein-1 (MCP-1), its receptor, and macrophages in the perifollicular stroma during the human ovulatory process. Fertil. Steril. 2009, 91:231-239.
24. Ujioka T., et al. Interleukin-8 as an essential factor in the human chorionic gonadotropin-induced rabbit ovulatory process: interleukin-8 induces neutrophil accumulation and activation in ovulation. Biol. Reprod. 1998, 58:526-530.
25. Krensky A.M., Clayberger C. Biology and clinical relevance of granulysin. Tissue Antigens 2009, 73:193-198.
26. Marcal J.R., et al. T-helper cell type 17/regulatory T-cell immunoregulatory balance in human radicular cysts and periapical granulomas. J. Endod. 2010, 36:995-999.
27. Riese J., et al. Expression of interleukin-6 and monocyte chemoattractant protein-1 by peritoneal sub-mesothelial cells during abdominal operations. J. Pathol. 2004, 202:34-40.
28. Yadav A., et al. MCP-1: chemoattractant with a role beyond immunity: a review. Clin. Chim. Acta 2010, 411:1570-1579.
29. Bornstein S.R., et al. Cytokines and steroidogenesis. Mol. Cell. Endocrinol. 2004, 215:135-141.
30. Wong K.H., et al. Expression, hormonal regulation, and cyclic variation of chemokines in the rat ovary: key determinants of the intraovarian residence of representatives of the white blood cell series. Endocrinology 2002, 143:784-791.
31. Dahm-Kahler P., et al. Monocyte chemotactic protein-1 in the follicle of the menstrual and IVF cycle. Mol. Hum. Reprod. 2006, 12:1-6.
32. Cohen P.E., et al. Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice disrupts estrous cycles and ovulation. Biol. Reprod. 1997, 56:110-118.
33. Cohen P.E., et al. Macrophages: important accessory cells for reproductive function. J. Leukoc. Biol. 1999, 66:765-772.
34. Van der Hoek K.H., et al. Intrabursal injection of clodronate liposomes causes macrophage depletion and inhibits ovulation in the mouse ovary. Biol. Reprod. 2000, 62:1059-1066.
35. Kunkel E.J., et al. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003, 10:313-323.
36. Youn B.S., et al. Role of the CC chemokine receptor 9/TECK interaction in apoptosis. Apoptosis 2002, 7:271-276.
37. Zhou C., et al. Transient expression of CC chemokine TECK in the ovary during ovulation: its potential role in ovulation. Am. J. Reprod. Immunol. 2005, 53:238-248.
38. + cell population and CC chemokine thymus-expressed chemokine in ovulation related inflammation. J. Immunol. 2009, 182:596-603.
39. Foster R., et al. A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model. Fertil. Steril. 2010, 93:1464-1476.
40. Buchweitz J.P., et al. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 2007, 35:424-435.
41. Szklarczyk A., Conant K. Matrix metalloproteinases, synaptic injury, and multiple sclerosis. Front. Psychiatry 2010, 1:12.
42. Jo M., Curry T.E. Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary. Biol. Reprod. 2004, 71:1796-1806.
43. Curry T.E., Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 2003, 24:428-465.
44. Duffy D.M., Stouffer R.L. Luteinizing hormone acts directly at granulosa cells to stimulate periovulatory processes: modulation of luteinizing hormone effects by prostaglandins. Endocrine 2003, 22:249-256.
45. Fedorcsak P., et al. Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes. Endocrinology 2010, 151:1290-1298.
46. Van Lint P., Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 2007, 82:1375-1381.
47. Reisinger K., et al. The gonadotropins: tissue-specific angiogenic factors?. Mol. Cell. Endocrinol. 2007, 269:65-80.
48. Chowdhury M.W., et al. The expression of angiogenic growth factors and their receptors in ovarian follicles throughout the estrous cycle in the ewe. Theriogenology 2010, 73:856-872.
49. Stouffer R.L., et al. Molecular control of ovulation and luteinization in the primate follicle. Front. Biosci. 2007, 12:297-307.
50. Gargett C.E., Rogers P.A. Human endometrial angiogenesis. Reproduction 2001, 121:181-186.
51. Heissig B., et al. Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. Histol. Histopathol. 2010, 25:765-770.
52. Guimera M., et al. LH/HCG stimulation of VEGF and adrenomedullin production by follicular fluid macrophages and luteinized granulosa cells. Reprod. Biomed. Online 2009, 18:743-749.
53. Belotti D., et al. Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion. Mol. Cancer Res. 2008, 6:525-534.
54. Channing C.P., et al. Ovarian follicular and luteal physiology. Int. Rev. Physiol. 1980, 22:117-201.
55. Bliss S.P., et al. GnRH signaling, the gonadotrope and endocrine control of fertility. Front. Neuroendocrinol. 2010, 31:322-340.
56. de la Iglesia H.O., Schwartz W.J. Minireview: timely ovulation: circadian regulation of the female hypothalamo-pituitary-gonadal axis. Endocrinology 2006, 147:1148-1153.
57. Doufas A.G., Mastorakos G. The hypothalamic-pituitary-thyroid axis and the female reproductive system. Ann. N. Y. Acad. Sci. 2000, 900:65-76.
58. Zeineh K., et al. Possible modulators of IL-8 and GRO-alpha production by granulosa cells. Am. J. Reprod. Immunol. 2003, 50:98-103.
59. Jokubkiene L., et al. Assessment of changes in volume and vascularity of the ovaries during the normal menstrual cycle using three-dimensional power Doppler ultrasound. Hum. Reprod. 2006, 21:2661-2668.
60. Shimada M., et al. Synaptosomal-associated protein 25 gene expression is hormonally regulated during ovulation and is involved in cytokine/chemokine exocytosis from granulosa cells. Mol. Endocrinol. 2007, 21:2487-2502.
61. Son D.S., Roby K.F. Interleukin-1alpha-induced chemokines in mouse granulosa cells: impact on keratinocyte chemoattractant chemokine, a CXC subfamily. Mol. Endocrinol. 2006, 20:2999-3013.
62. Szlosarek P.W., et al. Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol. Cancer Ther. 2006, 5:382-390.
63. Karstrom-Encrantz L., et al. Selective presence of the chemokine growth-regulated oncogene alpha (GROalpha) in the human follicle and secretion from cultured granulosa-lutein cells at ovulation. Mol. Hum. Reprod. 1998, 4:1077-1083.
64. Jasper M.J., et al. Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol. Reprod. 2000, 62:704-713.
65. Kluger M.S. Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv. Dermatol. 2004, 20:163-201.
66. Radi Z.A., et al. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. J. Vet. Intern. Med. 2001, 15:516-529.
67. Korpos E., et al. Multiple roles of the extracellular matrix in inflammation. Curr. Pharm. Des. 2009, 15:1349-1357.
68. Weber C., Koenen R.R. Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol. 2006, 27:268-273.
69. Pate J.L., et al. The interface of the immune and reproductive systems in the ovary: lessons learned from the corpus luteum of domestic animal models. Am. J. Reprod. Immunol. 2010, 64:275-286.
70. Robbins C.S., Swirski F.K. The multiple roles of monocyte subsets in steady state and inflammation. Cell. Mol. Life Sci. 2010, 67:2685-2693.
71. Leuschner F., et al. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ. Res. 2010, 107:1364-1373.
72. Popovich P.G., Hickey W.F. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J. Neuropathol. Exp. Neurol. 2001, 60:676-685.
73. Jovcic G., et al. Acute sterile inflammation - correlation between cellular changes and extramedullary-produced regulators in vivo. Ann. Hematol. 1993, 66:195-201.
74. Brannstrom M., et al. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol. Reprod. 1993, 48:277-286.
75. Godiska R., et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 1997, 185:1595-1604.
76. Tracy E.T., Rice H.E. Partial splenectomy for hereditary spherocytosis. Pediatr. Clin. North Am. 2008, 55:503-519. x.
77. Matsuyama S., et al. The critical period in which splenectomy causes functional disorder of the ovary in adult rats. Endocrinol. Jpn. 1987, 34:849-855.
78. Saito S., et al. Involvement of splenocytes in the control of corpus luteum function in the rat. Endocrinol. Jpn. 1988, 35:891-898.
79. Endo T., Kanayama K. Effects of splenectomy on luteal function in pseudopregnant rabbits. J. Int. Med. Res. 1998, 26:93-97.
80. Nariai K., et al. Effects of splenectomy on luteolysis in pseudopregnant rabbits. J. Vet. Med. Sci. 1995, 57:503-505.
81. You S., et al. Three different turkey luteinizing hormone receptor (tLH-R) isoforms I: characterization of alternatively spliced tLH-R isoforms and their regulated expression in diverse tissues. Biol. Reprod. 2000, 62:108-116.
82. Leuschner C., Hansel W. Targeting breast and prostate cancers through their hormone receptors. Biol. Reprod. 2005, 73:860-865.
83. Yoshimura Y., et al. Gonadotropin stimulates ovarian renin-angiotensin system in the rabbit. J. Clin. Invest. 1994, 93:180-187.
84. Pellicer A., et al. Blockage of ovulation by an angiotensin antagonist. Science 1988, 240:1660-1661.
85. Kuji N., et al. Involvement of angiotensin II in the process of gonadotropin-induced ovulation in rabbits. Biol. Reprod. 1996, 55:984-991.
86. Gomez-Lopez N., et al. Invasion of the leukocytes into the fetal-maternal interface during pregnancy. J. Leukoc. Biol. 2010, 88:625-633.
87. Nagamatsu T., Schust D.J. The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol. 2010, 63:460-471.
88. Christiaens I., et al. Inflammatory processes in preterm and term parturition. J. Reprod. Immunol. 2008, 79:50-57.
89. Barbieri F., et al. Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J. Mol. Endocrinol. 2007, 38:383-389.
90. Callewaere C., et al. Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J. Mol. Endocrinol. 2007, 38:355-363.
91. Rodriguez-Martinez H., et al. Boar spermatozoa in the oviduct. Theriogenology 2005, 63:514-535.
92. Matsuda H., et al. Tissue concentrations of eosinophilia in the bovine oviduct and uterus of different stages of the oestrous cycle. Res. Vet. Sci. 1983, 34:369-370.
93. van Bogaert L.J., et al. The percentage of granulocyte-like cells in human oviduct epithelium. Br. J. Obstet. Gynaecol. 1978, 85:373-375.
94. Hedger M.P. Testicular leukocytes: what are they doing?. Rev. Reprod. 1997, 2:38-47.
95. Chen B., et al. Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones?. Am. J. Obstet. Gynecol. 2005, 192:1605-1613.
96. Givan A.L., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am. J. Reprod. Immunol. 1997, 38:350-359.
97. Hill J.A., Anderson D.J. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am. J. Obstet. Gynecol. 1992, 166:720-726.
98. Li T.C., et al. Histological and clinical features of menstruation induced by the antiprogestin mifepristone (RU486) compared to menstruation occurring spontaneously. J. Obstet. Gynaecol. (Lahore) 1990, 10:411-414.
99. Bowen J.M., Keyes P.L. The proestrous prolactin surge is not the sole initiator of regressive changes in corpora lutea of normally cycling rats. Biol. Reprod. 1999, 61:1208-1215.
100. Bowen J.M., et al. Luteal regression in the normally cycling rat: apoptosis, monocyte chemoattractant protein-1, and inflammatory cell involvement. Biol. Reprod. 1999, 60:740-746.
101. Hameed A., et al. Perforin expression in human cell-mediated luteolysis. Int. J. Gynecol. Pathol. 1995, 14:151-157.
102. Olson K.K., Townson D.H. Prolactin-induced expression of intercellular adhesion molecule-1 and the accumulation of monocytes/macrophages during regression of the rat corpus luteum. Biol. Reprod. 2000, 62:1571-1578.
103. Olson K.K., et al. Actions of prostaglandin F2alpha and prolactin on intercellular adhesion molecule-1 expression and monocyte/macrophage accumulation in the rat corpus luteum. Biol. Reprod. 2001, 64:890-897.
104. Nagaosa K., et al. Determination of cell type specificity and estrous cycle dependency of monocyte chemoattractant protein-1 expression in corpora lutea of normally cycling rats in relation to apoptosis and monocyte/macrophage accumulation. Biol. Reprod. 2002, 67:1502-1508.
105. Bowen J.M., et al. Prolactin-induced regression of the rat corpus luteum: expression of monocyte chemoattractant protein-1 and invasion of macrophages. Biol. Reprod. 1996, 54:1120-1127.
106. Kuranaga E., et al. Fas/Fas ligand system in prolactin-induced apoptosis in rat corpus luteum: possible role of luteal immune cells. Biochem. Biophys. Res. Commun. 1999, 260:167-173.
107. Wu R., et al. Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome. Hum. Reprod. 2007, 22:527-535.
108. Gaytan F., et al. Role of prolactin in the regulation of macrophages and in the proliferative activity of vascular cells in newly formed and regressing rat corpora lutea. Biol. Reprod. 1997, 57:478-486.
109. Brannstrom M., Enskog A. Leukocyte networks and ovulation. J. Reprod. Immunol. 2002, 57:47-60.
110. Kucharski J., Jana B. Immuno-endocrine mechanisms connected with the creation of corpora lutea persistent in animal ovaries. Pol. J. Vet. Sci. 2005, 8:255-259.
111. Gaytan F., et al. Effects of indomethacin on ovarian leukocytes during the periovulatory period in the rat. Reprod. Biol. Endocrinol. 2003, 1:26.
112. Das S., et al. Follicular fluid expression of alpha-defensins and their role in ovulation. J. Assist. Reprod. Genet. 2008, 25:83-87.
113. El-Nefiawy N., et al. Role of prostaglandin E2 receptor subtypes in ovarian follicle growth in the rat in vivo Correlation with interleukin-8 and neutrophils. Histol. Histopathol. 2005, 20:825-831.
114. - natural killer cells accumulate in the ovarian follicular fluid of patients undergoing in vitro fertilization. Fertil. Steril. 2010, 94:1918-1921.
115. Karaca T., Simsek N. Effects of spirulina on the number of ovary mast cells in lead-induced toxicity in rats. Phytother. Res. 2007, 21:44-46.
116. Gaytan F., et al. Estrous cycle-related changes in mast cell numbers in several ovarian compartments in the rat. Biol. Reprod. 1991, 45:27-33.
117. Vogel B., et al. Bovine eotaxin (CCL11) - an unusual member of the eotaxin group - attracts eosinophils in vitro but is not responsible for eosinophilia in the ovary. Vet. Immunol. Immunopathol. 2005, 107:67-77.
118. Yuan G.H., et al. Role of chemokines/chemokine receptor systems in cartilage degradation. Drug News Perspect. 2001, 14:591-600.
119. Skinner M.K., et al. Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle development. Mol. Reprod. Dev. 2008, 75:1457-1472.
120. Eberlein J., et al. Comprehensive assessment of chemokine expression profiles by flow cytometry. J. Clin. Invest. 2010, 120:907-923.
121. Williams I.R. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann. N. Y. Acad. Sci. 2006, 1072:52-61.
122. Dewan M.Z., et al. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed. Pharmacother. 2006, 60:273-276.
123. + cells by the nervous system. Brain Behav. Immun. 2009, 23:1059-1065.